Related Experiment Videos
Protein losing enteropathy associated with collagen diseases
A Tsutsumi1, T Sugiyama, R Matsumura
1Second Department of Internal Medicine, Chiba University School of Medicine, Japan.
Annals of the Rheumatic Diseases
|March 1, 1991
Summary
Protein losing enteropathy in collagen diseases improved with oral prednisolone treatment. Autoimmune factors may cause increased intestinal permeability in these patients.
Area of Science:
- Gastroenterology
- Rheumatology
- Immunology
Background:
- Collagen diseases are systemic autoimmune conditions affecting connective tissues.
- Protein losing enteropathy (PLE) is a rare complication characterized by excessive gastrointestinal protein loss.
Observation:
- Four patients with collagen diseases presented with PLE.
- Symptoms of PLE resolved in all patients after treatment with oral prednisolone (60 mg/day).
Findings:
- Immunohistological examination of small intestinal villi revealed C3 deposits in capillary walls in two patients.
- These findings suggest potential autoimmune involvement in the pathogenesis of PLE in collagen diseases.
Implications:
- Oral prednisolone may be an effective treatment for PLE associated with collagen diseases.
- Understanding the role of autoimmune phenomena can guide future therapeutic strategies for PLE in connective tissue disorders.